ERBB2 and breast carcinoma: Although this result did not reach statistical significance, our observation regarding HER2 does not seem to be influenced by the metastatic tropism of HER2-positive breast cancers, and it might reveal important insights into the signaling networks involving CTC cluster formation, also considering HER2 expression fluctuations in CTCs and breast cancer metastasis [15, 16].